EYEMED VISION CARE - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Serial Number
77409372
Word Mark
EYEMED VISION CARE
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2009-01-14
Filing Date
2008-02-29
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
010113, 261713 - More than one star with five points. Letters or words underlined and/or overlined by one or more strokes or lines.
Law Office Assigned Location Code
M80
Employee Name
MAHONEY, PAULA M
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of the word mark EYEMED and two star designs positioned over the words Vision Care .
Goods and Services
Administration of pre-paid health care plans, namely, vision care benefits programs provided to members of health maintenance programs
Pseudo Mark
EYE MED VISION CARE
Classification Information
International Class
36 - Insurance; financial affairs; monetary affairs; real estate affairs. - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes
100, 101, 102
Class Status Code
6 - Active
Class Status Date
2008-03-05
Primary Code
036
First Use Anywhere Date
1997-06-30
First Use In Commerce Date
1997-06-30
Correspondences
Name
THE UNITED STATES SHOE CORPORATION
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship Type | Reel Number |
Prior Registration | 2367100 |
Prior Registration | 2631181 |
Prior Registration | 3268032 |
Trademark Events
Event Date | Event Description |
2008-03-05 | NEW APPLICATION ENTERED IN TRAM |
2008-03-06 | NOTICE OF DESIGN SEARCH CODE AND PSEUDO MARK MAILED |
2008-06-10 | ASSIGNED TO EXAMINER |
2008-06-16 | NON-FINAL ACTION WRITTEN |
2008-06-17 | NON-FINAL ACTION MAILED |
2009-01-14 | ASSIGNED TO EXAMINER |
2009-01-14 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
2009-01-15 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |